Ocular Therapeutix
OCUL
OCUL
64 hedge funds and large institutions have $201M invested in Ocular Therapeutix in 2016 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
10% less funds holding
Funds holding: 71 → 64 (-7)
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
Holders
64
Holding in Top 10
3
Calls
$788K
Puts
$162K
Top Buyers
| 1 | +$6.26M | |
| 2 | +$2.12M | |
| 3 | +$1.26M | |
| 4 |
D.E. Shaw & Co
New York
|
+$867K |
| 5 |
CCI
Columbus Circle Investors
|
+$827K |
Top Sellers
| 1 | -$5.13M | |
| 2 | -$2.6M | |
| 3 | -$1.45M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$1.42M |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$898K |